DRKS00031653
Recruiting
未知
Complete revascularization versus culprit lesion only PCI in NSTEMI - COMPLETE-NSTEMI
eipzig Heart Science gGmbH0 sites3,390 target enrollmentApril 17, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- non-ST-elevation myocardial infarction (NSTEMI)Multivessel coronary artery disease
- Sponsor
- eipzig Heart Science gGmbH
- Enrollment
- 3390
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •NSTEMI as suggested by high\-sensitivity troponin algorithms
- •Multivessel coronary artery disease
- •Identifiable culprit lesion
- •Informed consent
Exclusion Criteria
- •Cardiogenic shock
- •Sustained ventricular tachycardia (VT) or ventricular fibrillation (VF)
- •Contraindication for coronary revascularization
- •Prior coronary artery bypass graft
- •Indication for coronary artery bypass graft surgery
- •Co\-morbidity with life expectancy less than 6 months
- •Type 2 myocardial infarction
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
REvascularization versus optimal medical therapy on left Ventricular ISchemia reduction: Exploring the associations between ischemia, functional outcome and collaterals in the treatment of Chronic Total Occlusion patientsNL-OMON49007Academisch Medisch Centrum82
Recruiting
Not Applicable
Ischemia (FFR) Driven Complete Revascularization versus Usual Care in Patients with Non-ST Elevation Myocardial Infarction and Multivessel Diseases.Non-STEMI and multivessel disease10011082NL-OMON50726Zuyderland Medisch Centrum414
Not yet recruiting
Not Applicable
Ischemia (FFR) Driven Complete Revascularization versus Usual Care in Patients with Non-ST Elevation Myocardial Infarction and Multivessel Diseases. The South Limburg Myocardial Infarction Study GroupNL-OMON23247Zuyderland Medical Centre, Heerlen, The NetherlandsandMaastricht University Medical Centre +, Maastricht, The Netherlands414
Completed
Not Applicable
Clinical Outcomes Utilising Revascularisation and Aggressive Drug EvaluatioISRCTN18172323Department of Veteran Affairs, U.S. Federal Government and McMaster University Faculty of Health Sciences (Canada)2,546
Recruiting
Not Applicable
Revascularization versus Medical Treatment in Patients with Ischemic Left Ventricular dysfunctioDiseases of the circulatory systemKCT0008380Samsung Medical Center900